EVH vs PATH
Evolent Health Inc (EVH) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Evolent Health Inc (EVH) is a health information services company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported EVH revenue for 2024-12-31 was $646.5M. Net income was -$22.8M. Revenue was up 4.0% from 2024-09-30 to 2024-12-31. EVH currently screens at market cap $474.7M.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
EVH currently screens at market cap $474.7M. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the EVH and PATH stock pages for the full models.
Not investment advice.